Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy

The American Journal of Medicine
R I FisherR C Young

Abstract

Combination chemotherapy can dramatically improve the survival of those patients with advanced diffuse histiocytic lymphoma who enter complete remission. The age, sex, stage, constitutional symptoms, sites of disease and tumor mass of 56 consecutive patients with advanced diffuse histiocytic lymphoma were analyzed as prognostic factors. Twenty-four patients received cytoxan, vincristine, procarbazine and prednisone (C-MOPP) and 32 patients received bleomycin, adriamycin, cytoxan, vincristine and prednisone (BACOP). In 26 of 56 (46 per cent) a complete remission was achieved, in 21 of 56 (38 per cent) a partial remission and in nine of 56 (16 per cent) no response. Median survival with a complete remission was not reached at three years with 82 per cent still alive, but was significantly greater than with a partial remission (7.6 months median) or no response (3.2 months median). Survival of those with a partial remission and no response did not differ statistically. Stage IV disease, bone marrow involvement, gastrointestinal involvement and a tumor mass greater than 10 cm in diameter in a single location were all poor prognostic factors. No other analyzed factor significantly affected survival in this study. Complete response r...Continue Reading

Citations

Jan 1, 1986·Journal of Cancer Research and Clinical Oncology·J P Dutcher, P H Wiernik
Jan 15, 1985·Klinische Wochenschrift·W SiegertD Huhn
Dec 21, 1978·The New England Journal of Medicine·J A StrauchenC W Berard
Mar 13, 1980·The New England Journal of Medicine·P Lenner
Aug 7, 1980·The New England Journal of Medicine·R WarnkeR Levy
Jul 16, 1981·The New England Journal of Medicine·R C YoungC E Myers
Apr 1, 1984·The Journal of Clinical Investigation·S E ShackneyJ W Parker
Nov 10, 2000·International Journal of Radiation Oncology, Biology, Physics·P J SchlembachJ D Cox
Jan 1, 1979·Pharmacology & Therapeutics·B J Lewis, V T DeVita
Sep 1, 1979·International Journal of Radiation Oncology, Biology, Physics·J T LeimertR D Gingrich
Oct 1, 1979·Clinics in Haematology·A T Skarin, G P Canellos
Apr 1, 1981·Pathology, Research and Practice·P MeusersG Brittinger
Jul 1, 1984·European Journal of Cancer & Clinical Oncology·W P StewardD Crowther
Jan 1, 1992·Critical Reviews in Oncology/hematology·M R MirzaL Specht
Jun 1, 1993·Leukemia & Lymphoma·P E Goss
Jun 19, 2015·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Hirotaka TakasakiRika Sakai
Jun 24, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas P Miller
Nov 1, 1980·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G BlackledgeP M Wilkinson
Dec 17, 2017·Journal of Experimental & Clinical Cancer Research : CR·Haige YeMichael L Wang
Aug 1, 1984·Cancer·D S ShimmC C Wang
Aug 1, 1978·Cancer·G P CanellosA T Skarin
Dec 1, 1983·Cancer·H J ReeJ P Crowley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.